Overview

An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
A review of the amount of drug in your blood over time.
Phase:
Phase 1
Details
Lead Sponsor:
Luye Pharma Group Ltd.
Treatments:
Risperidone